Prevalence of sarcopenia in the elderly population in Costa Rica

Authors

  • Isabel Barrientos-Calvo Hospital Nacional de Geriatría y Gerontología, Departamento de Geriatría y Soporte Nutricional, Costa Rica
  • Ernesto Picado-Ovares Hospital Nacional de Geriatría y Gerontología, Departamento de Atención Comunitaria , Costa Rica

DOI:

https://doi.org/10.51481/amc.v63i2.1121

Keywords:

Prevalence, Sarcopenia, Aged, Costa Rica

Abstract

Background: Sarcopenia is the progressive loss of mass and skeletal muscle strength. Its prevalence varies in the different reviews carried out, this by the different measurement methods. Costa Rica does not have data on its prevalence

Objective: The aim of this study is to know the prevalence of sarcopenia and associated factors with it in older people from Costa Rican Study of Longevity and Healthy Ageing.

Methods: A subgroup of 2516 people was analyze, using the European Working Group on Sarcopenia in Older People diagnostic criteria that include low muscle mass and low muscle strength. Muscle mass was assessed using calf circumference < 31 cm and grip strength using dynamometer, was low strength if <27 kg in men or <16 kg in women.

Results:The prevalence of sarcopenia was 10.26%. There was an increasing trend of sarcopenia by age group, it was more prevalent in women. Some characteristics of Costa Ricans with sarcopenia was that most of them had less income, lived accompanied, perceived as unhealthy, had incomplete primary education. The weight, brachial, abdominal and calf circumference was lower in people with sarcopenia. Sarcopenia was positively associated with age (OR 3,164; IC 1,962-5,101), education (OR 4,264; IC 1,547-11,753), perceived as unhealthy (OR 1,691; IC 1,133-2,525), antecedent of ischemic vascular event (OR 3,221; IC 1,566-6,628), arthritis (OR 1,648; IC 1,044-2,601), and falls (0R 1,676; IC 1,143-2,458).

Conclusions: The prevalence of sarcopenia was 10.26%, similar to other countries of Latin America. It increase with age.

Downloads

Download data is not yet available.

References

Studenski SA, Peters KW, Alley DE, Cawthon PM, McLean RR, Harris TB et al. The FNIH sarcopenia project: rationale, study description, conference recommendations, and final estimates. J Gerontol A Biol Sci Med Sci. 2014; 69:547-58. doi:10.1093/gerona/glu010

Cruz-Jentoft AJ, Bahat G, Bauer J, Boirie Y, Bruyére O, Cederholm T et al. Revised European consensus on definition and diagnosis. Age Ageing. 2019; 48:16-31. doi: 10.1093/ageing/afy169.

Coker R, Wolfe R. Bedrest and sarcopenia. Curr Opin Clin Nutr Metab Care. 2012; 15:7-11. doi: 10.1097/MCO.0b013e32834da629

Legrand D, Vaes B, Matheï C, Swine Ch, Degryse J. The prevalence of sarcopenia in very old individuals according to the European consensus definition: insights from the BELFRAIL study. Age and Ageing. 2013; 42: 727-734. doi.org/10.1093/ageing/aft128

Zhang T, Cao L, Cao T, Yang J, Gong J, Zhu W et al. Prevalence of Sarcopenia and Its Impact on Postoperative Outcome in Patients With Crohn's Disease Undergoing Bowel Resection. J Parenter Enteral Nutr. 2017;41:592-600. doi: 10.1177/0148607115612054.

Bahat G, Tufan F, Killic C, Akpinar TS, Kose M, Erten N et al. Cut-off points to identify sarcopenia according to European Working Group on Sarcopenia in Older People (EWGSOP) definition. Clin Nutr. 2016; 35:1557-1563. doi: 10.1016/j.clnu.2016.02.002

Volpato S, Lara B, Cherubini A, Landi F, Maggio M, Savino E et al. Prevalence and Clinical Correlates of Sarcopenia in Community-Dwelling Older People: Application of the EWGSOP Definition and Diagnostic Algorithm. J Gerontol A Biol Sci Med Sci. 2014;69:438-446. doi: 10.1093/gerona/glt149

Beaudart C, Reginster JY, Slomian J, Buckinx F, Locquet M, Bruyére O. Prevalence of sarcopenia: the impact of different diagnostic cut-off limits. J Musculoskelet Neuronal Interact. 2014 Dec;14:425-31

Buckinx F, Landi F, Cesari M, Fielding R, Visser M, Engelke K et al. Pitfalls in the measurement of muscle mass: a need for a reference standard. J Cachexia Sarcopenia Muscle. 2018; 9: 269-278. 10.1002/jcsm.12268

Newman AB, Kupelian V, Visser M, Simonsick E, Goodpaster B, Nevitt M et al. Health ABC Study Investigators. Sarcopenia: alternative definitions and associations with lower extremity function. J Am Geriatr Soc. 2003; 51:1602- 1609

Cruz-Jentoft AJ, Landi F, Schneider SM, Zuñiga C, Arai H, Boirie Y et al. Prevalence of and interventions for sarcopenia in ageing adults: a systematic review. Report of the International Sarcopenia Initiative (EWGSOP and IWGS). Age Ageing. 2014; 43:748-759. doi:10.1093/ageing/afu115

Arango-Lopera VE, Arroyo P, Gutiérrez-Robledo L, Pérez-Zepeda M. Prevalence of sarcopenia in Mexico City. Eur Geriatr Med. 2012; 3: 157-160. doi:10.1016/j.eurger.2011.12.001

Pérez-Zepeda M, Sánchez-Garrido N, González-Lara M y Gutiérrez- Robledo LM. Sarcopenia prevalence using simple measurements and population-based cutoff values. J Lat Am Geriatr Med. 2016; 2: 8-13

Woo J. Nutritional interventions in sarcopenia: where do we stand? Current Opinion in Clinical Nutrition & Metabolic Care. 2018; 21:19-23. doi:10.1097/MCO.0000000000000432

Rosero-Bixby L, Fernández X, and Dow W. CRELES: Costa Rican Longevity and Healthy Aging Study, 2005 (Costa Rica Estudio de Longevidad y Envejecimiento Saludable). Disponible en: http://ccp.ucr.ac.cr/index.php/creles-inicio.html

Rosero-Bixby L. CRELES- Costa Rica: Estudio de Longevidad y Envejecimiento Saludable. Poblac Salud Mesoam. 2007; 5. Disponible en: http://revistas.ucr.ac.cr

Samper-Ternent R, Reyes-Ortiz C y Cano C. Frailty and sarcopenia in Bogotá: results from the SABE Bogota Study. Aging Clin Exp Res. 2017 Apr;29:265-272. doi: 10.1007/s40520-016-0561-2

Lera L, Albala C, Sánchez H, Angel B, Hormazabal MJ, Márquez C, Arroyo P. Prevalence of Sarcopenia in Community-Dwelling Chilean Elders According to an Adapted Version of the European Working Group on Sarcopenia in Older People (EWGSOP) Criteria. J Frailty Aging. 2017;6:12-17. doi: 10.14283/jfa.2016.117

Alexandre T da S, Duarte YA de O, Santos JLF, Wong R, Lebrão ML. Prevalence and associated factors of sarcopenia among elderly in Brazil: findings from the SABE study. J Nutr Health Aging. 2014;18:284-90. doi: 10.1007/s12603-013-0413-0

Rolland Y, Lauwers-Cances V, Cournot M et al. Sarcopenia, calf circumference, and physical function of elderly women: a cross-sectional study. J Am Geriatr Soc. 2003; 51: 1120-1124

Landi F, Onder G, Russo A et al. Calf circumference, frailty and physical performance among older adults living in the community. Clin Nutr. 2014; 33: 539-544. doi: 10.1016/j.clnu.2013.07.013

Velázquez M, Irigoyen M, Lazarevich I, Delgadillo J, Acosta P, Zepeda M. Comparison of the prevalence of sarcopenia using skeletal muscle mass index and calf circumference applying the European consensus definition in elderly Mexican women. Geriatr Geront Int. 2017;17:161-170. doi: 10.1111/ggi.12652

Lera L, Ángel B, Sánchez H, Picrin Y, Hormazabal M, Quiero A y Albala C. Estimación y validación de puntos de corte de índice de masa muscular esquelética para la identificación de sarcopenia en adultos mayores chilenos. Nutr Hosp. 2015;31:1187-1197. doi: 10.3305/nh.2015.31.3.8054

Masanés F, Rojano X, Salvá A, Serra-Resach JA, Artaza I, Formiga F et al. Cut-off Points for Muscle Mass - Not Grip Strength or Gait Speed - Determine Variations in Sarcopenia Prevalence. J NUTR Health Aging. 2017;21:825-829. doi: 10.1007/s12603-016-0844-5.

Alley D, Shardell M, Peters K, McLean R, Dam T, Kenny A et al. Grip strength cutpoints for the identification of clinically relevant weakness. J Gerontol A Biol Sci Med Sci. 2014 May;69:559-66. doi:10.1093/gerona/glu011.

Syddall H, Westbury L, Cooper C, Sayer A. Self- reported walking speed: a useful marker of physical performance among community-dwelling older people? J Am Med Dir Assoc. 2015; 16: 323-328. doi:10.1016/j.jamda.2014.11.004

Published

2021-12-14

How to Cite

Prevalence of sarcopenia in the elderly population in Costa Rica. (2021). Acta Médica Costarricense , 63(2), 122-130. https://doi.org/10.51481/amc.v63i2.1121